GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Asset Impairment Charge

G.Barekat Pharm (XTEH:BRKT1) Asset Impairment Charge : IRR0 Mil (TTM As of Mar. 2017)


View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Asset Impairment Charge?

G.Barekat Pharm's Asset Impairment Charge for the six months ended in Mar. 2017 was IRR0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2017 was IRR0 Mil.

G.Barekat Pharm Asset Impairment Charge Historical Data

The historical data trend for G.Barekat Pharm's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Asset Impairment Charge Chart

G.Barekat Pharm Annual Data
Trend Mar16 Mar17
Asset Impairment Charge
- -

G.Barekat Pharm Semi-Annual Data
Mar16 Mar17
Asset Impairment Charge - -

G.Barekat Pharm Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2017 was IRR0 Mil.

G.Barekat Pharm Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Asset Impairment Charge
Comparable Companies
PRGBQ BOM:532041 PZRXQ NSPX HSTC BOM:540108 XCNQ:ZRO XSAT:EURI B BOM:524604 BOM:532905 VODG BOM:506365 SOAN TSXV:WAVE PTEO BPSR CBBT LSE:PEBI ADYNF NTRR
Traded in Other Exchanges
N/A
Address
No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN
Website
http://www.bpharmed.com
G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines